Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= ITGAV ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: ITGAV * **<color #00a2e8>Official Name</color>**: integrin subunit alpha V * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3685|3685]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P06756|P06756]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=ITGAV&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ITGAV|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/193210|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: N/A * **<color #00a2e8>UniProt Summary</color>**: The alpha-V (ITGAV) integrins are receptors for vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin and vWF. They recognize the sequence R-G-D in a wide array of ligands. ITGAV:ITGB3 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415). ITGAV:ITGB3 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGAV:ITGB3 binds to FGF1 and this binding is essential for FGF1 signaling (PubMed:18441324). ITGAV:ITGB3 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:19578119). ITGAV:ITGB3 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGAV:ITGB3 and ITGAV:ITGB6 act as a receptor for fibrillin-1 (FBN1) and mediate R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887, PubMed:17158881). {ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:19578119, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:25398877}. (Microbial infection) Integrin ITGAV:ITGB5 and ITGAV:ITGB3 act as receptors for Coxsackievirus A9 and B1. {ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:7519807, ECO:0000269|PubMed:9426447}. (Microbial infection) Integrin ITGAV:ITGB6 acts as a receptor for herpes simplex 1/HHV-1. {ECO:0000269|PubMed:24367260}. (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for West nile virus. {ECO:0000269|PubMed:23658209}. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |Integrin alpha2| |FG-GAP| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |opsonin binding| |modulation of phagocytosis in other organism involved in symbiotic interaction| |positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction| |positive regulation by symbiont of host phagocytosis| |modulation by symbiont of host phagocytosis| |entry of symbiont into host cell by promotion of host phagocytosis| |integrin alphav-beta3 complex| |integrin alphav-beta5 complex| |negative regulation of entry of bacterium into host cell| |integrin alphav-beta8 complex| |transforming growth factor-beta secretion| |integrin alphav-beta6 complex| |alphav-beta3 integrin-HMGB1 complex| |alphav-beta3 integrin-PKCalpha complex| |negative regulation of low-density lipoprotein particle receptor biosynthetic process| |negative regulation of lipoprotein metabolic process| |alphav-beta3 integrin-IGF-1-IGF1R complex| |C-X3-C chemokine binding| |neuregulin binding| |apolipoprotein A-I-mediated signaling pathway| |extracellular matrix protein binding| |negative regulation of receptor biosynthetic process| |regulation of entry of bacterium into host cell| |regulation of transforming growth factor beta activation| |regulation of low-density lipoprotein particle receptor biosynthetic process| |positive regulation of osteoblast proliferation| |insulin-like growth factor I binding| |regulation of lipoprotein metabolic process| |negative regulation of macrophage derived foam cell differentiation| |filopodium membrane| |negative regulation of lipid storage| |lamellipodium membrane| |regulation of osteoblast proliferation| |transforming growth factor beta binding| |cell adhesion mediated by integrin| |regulation of receptor biosynthetic process| |fibroblast growth factor binding| |microvillus membrane| |integrin complex| |modulation by symbiont of host cellular process| |negative regulation of lipid transport| |fibronectin binding| |extracellular matrix binding| |ERK1 and ERK2 cascade| |regulation of macrophage derived foam cell differentiation| |signal transduction in absence of ligand| |extrinsic apoptotic signaling pathway in absence of ligand| |coreceptor activity| |regulation of transforming growth factor beta production| |heterotypic cell-cell adhesion| |apoptotic cell clearance| |voltage-gated calcium channel activity| |negative regulation of lipid localization| |endodermal cell differentiation| |modification by symbiont of host morphology or physiology| |regulation of lipid storage| |negative chemotaxis| |endoderm formation| |cytokine secretion| |substrate adhesion-dependent cell spreading| |protein kinase C binding| |phagocytic vesicle| |vascular endothelial growth factor receptor signaling pathway| |vasculogenesis| |positive regulation of phagocytosis| |endoderm development| |antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent| |virus receptor activity| |antigen processing and presentation of exogenous peptide antigen via MHC class I| |specific granule membrane| |integrin-mediated signaling pathway| |viral entry into host cell| |regulation of phagocytosis| |ruffle membrane| |extrinsic apoptotic signaling pathway| |antigen processing and presentation of peptide antigen via MHC class I| |negative regulation of extrinsic apoptotic signaling pathway| |entry into host| |protease binding| |entry into host cell| |regulation of lipid transport| |modification of morphology or physiology of other organism involved in symbiotic interaction| |formation of primary germ layer| |cell-matrix adhesion| |integrin binding| |regulation of lipid localization| |cytokine production| |regulation of extrinsic apoptotic signaling pathway| |modification of morphology or physiology of other organism| |interaction with host| |protein secretion| |gastrulation| |establishment of protein localization to extracellular region| |protein localization to extracellular region| |peptide secretion| |antigen processing and presentation of exogenous peptide antigen| |antigen processing and presentation of exogenous antigen| |cell-substrate adhesion| |antigen processing and presentation of peptide antigen| |calcium ion transmembrane transport| |viral life cycle| |negative regulation of multi-organism process| |antigen processing and presentation| |regulation of symbiosis, encompassing mutualism through parasitism| |negative regulation of apoptotic signaling pathway| |calcium ion transport| |positive regulation of cytosolic calcium ion concentration| |apoptotic signaling pathway| |divalent metal ion transport| |divalent inorganic cation transport| |angiogenesis| |regulation of cytosolic calcium ion concentration| |phagocytosis| |extracellular matrix organization| |MAPK cascade| |leukocyte migration| |extracellular structure organization| |signal transduction by protein phosphorylation| |external side of plasma membrane| |regulation of apoptotic signaling pathway| |positive regulation of cell adhesion| |blood vessel morphogenesis| |focal adhesion| |cellular calcium ion homeostasis| |calcium ion homeostasis| |cellular divalent inorganic cation homeostasis| |negative regulation of transport| |blood vessel development| |neutrophil degranulation| |divalent inorganic cation homeostasis| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |positive regulation of cell migration| |neutrophil activation| |granulocyte activation| |cell-cell adhesion| |transmembrane receptor protein tyrosine kinase signaling pathway| |vasculature development| |leukocyte degranulation| |cardiovascular system development| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |positive regulation of cell motility| |positive regulation of cellular component movement| |regulation of vesicle-mediated transport| |chemotaxis| |taxis| |positive regulation of locomotion| |cell morphogenesis involved in differentiation| |cellular metal ion homeostasis| |inorganic cation transmembrane transport| |embryonic morphogenesis| |myeloid leukocyte activation| |cation transmembrane transport| |cell surface| |leukocyte activation involved in immune response| |metal ion homeostasis| |cell activation involved in immune response| |cellular cation homeostasis| |metal ion transport| |cellular ion homeostasis| |inorganic ion transmembrane transport| |tube morphogenesis| |regulation of cell adhesion| |regulation of cytokine production| |viral process| |regulated exocytosis| |cation homeostasis| |negative regulation of cell differentiation| |enzyme linked receptor protein signaling pathway| |inorganic ion homeostasis| |cell morphogenesis| |cellular chemical homeostasis| |leukocyte mediated immunity| |regulation of multi-organism process| |symbiotic process| |ion homeostasis| |exocytosis| |interspecies interaction between organisms| |cellular component morphogenesis| |cation transport| |tube development| |regulation of cell migration| |circulatory system development| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |cellular homeostasis| |negative regulation of programmed cell death| |regulation of cell motility| |positive regulation of cell population proliferation| |apoptotic process| |leukocyte activation| |cell adhesion| |biological adhesion| |negative regulation of developmental process| |ion transmembrane transport| |cell migration| |protein phosphorylation| |embryo development| |regulation of locomotion| |positive regulation of transport| |negative regulation of cell death| |regulation of cellular component movement| |secretion by cell| |export from cell| |programmed cell death| |cell activation| |localization of cell| |cell motility| |cell death| |immune effector process| |negative regulation of protein metabolic process| |chemical homeostasis| |secretion| |negative regulation of signal transduction| |transmembrane transport| |phosphorylation| |locomotion| |negative regulation of cell communication| |negative regulation of signaling| |ion transport| |integral component of plasma membrane| |negative regulation of macromolecule biosynthetic process| |protein transport| |peptide transport| |regulation of apoptotic process| |negative regulation of biosynthetic process| |movement of cell or subcellular component| |regulation of programmed cell death| |amide transport| |establishment of protein localization| |regulation of cell population proliferation| |negative regulation of response to stimulus| |homeostatic process| |cell development| |regulation of cell death| |intracellular signal transduction| |tissue development| |regulation of cell differentiation| |nitrogen compound transport| |regulation of transport| |immune response| |vesicle-mediated transport| |membrane| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp389|PF-06409577 20μM R07 exp389]]|-1.89| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> No correlation found to any other genes in chemogenomics. </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 144/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|6/28| |blood|0/28| |bone|2/26| |breast|8/33| |central nervous system|20/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|1/1| |gastric|2/16| |kidney|11/21| |liver|9/20| |lung|21/75| |lymphocyte|0/16| |ovary|4/26| |pancreas|6/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|6/24| |soft tissue|4/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|7/29| |uterus|1/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 14257 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 4.05 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='ITGAV Expression in NALM6 Cells: 4.05'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2025/12/10 20:19by 127.0.0.1